HCC: East meets West

Monday, March 6, 2023

3:00 PM – 4:30 PM

Location:Phoenix Convention Center, 129AB

CE: 1.5 Credits

Coordinator(s)

RL

Robert Lewandowski, MD, FSIR

Professor
Northwestern University

Disclosure(s): ABK Biomedical: Consultant (Ongoing); Acerta/AstraZeneca: Advisory Committee or Review Panel Member (Ongoing); BD: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Speaking and Teaching (Ongoing); Varian Interventional Solutions: Consultant (Ongoing)
Uei Pua, MBBS, MMED, FRCR, FAMS, FSIR, FCIRSE, FSCAI

Senior Consultant
Tan Tok Seng Hospital

Disclosure(s): No financial relationships to disclose
Edward Kim, MD

Professor of Radiology
Mount Sinai Health System

Disclosure information not submitted.

Disclosure(s):

Robert Lewandowski, MD, FSIR: ABK Biomedical: Consultant (Ongoing); Acerta/AstraZeneca: Advisory Committee or Review Panel Member (Ongoing); BD: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Speaking and Teaching (Ongoing); Varian Interventional Solutions: Consultant (Ongoing)

Uei Pua, MBBS, MMED, FRCR, FAMS, FSIR, FCIRSE, FSCAI: No financial relationships to disclose

This course will provide a global, contemporary approach to liver-directed therapies for Hepatocellular Carcinoma (HCC). Attendees will be able to interact with international interventional radiologists, discussing optimal HCC treatments. The course will highlight treatment approaches in Eastern versus Western countries.

Learning Objectives:

Learn global, contemporary approaches to treating HCC
Discern differences in treatment approach between Eastern and Western countries
Gain insight on a personalized approach to treating patients with HCC

Presentations:

3:00 PM – 3:10 PM

Early-Stage HCC: Ablation
Speaker: Thierry De Baere, Physician – Gustave Roussy
3:10 PM – 3:20 PM

Early-Stage HCC: Pushing Boundaries of Ablation
Speaker: Somrach Thamtorawat, MD (he/him/his) – Siriraj Hospital, Mahidol University
3:20 PM – 3:30 PM

Early-Stage HCC when ablation is not an option: Eastern perspective
Speaker: Jin Woo Choi, MD (he/him/his) – Seoul National University Hospital
3:30 PM – 3:40 PM

Early-Stage HCC when ablation is not an option: Western perspective
Speaker: Edward Kim, MD – Mount Sinai Health System
3:40 PM – 3:50 PM

Panel Discussion
Speaker: Thierry De Baere, Physician – Gustave Roussy
Speaker: Edward Kim, MD – Mount Sinai Health System
3:50 PM – 4:00 PM

Large HCC and/or Portal Vascular Invasion: Western perspective
Speaker: Robert Lewandowski, MD, FSIR – Northwestern University
4:00 PM – 4:10 PM

Large HCC and/or Portal Vascular Invasion: Eastern perspective
Speaker: Hyo-Cheol Kim, MD – Seoul National University Hospital
4:10 PM – 4:20 PM

Treatment of intermediate HCC (TACE vs TARE vs systemic therapy)
Speaker: Suyash Sureshchandra Kulkarni, DMRD, DNB (he/him/his) – TATA MEMORIAL CENTRE
4:20 PM – 4:30 PM

Panel Discussion
Speaker: Hyo-Cheol Kim, MD – Seoul National University Hospital
Speaker: Suyash Sureshchandra Kulkarni, DMRD, DNB (he/him/his) – TATA MEMORIAL CENTRE